Research ArticleOriginal Article

The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study

Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413

Article Information

vol. 18 no. 3 841-848
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2020.0413
Published By 
Cancer Biology & Medicine
History 
  • Received August 7, 2020
  • Accepted October 26, 2020
  • Published online August 1, 2021.
Copyright & Usage 
Copyright: © 2021, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Wei Zhang1,
  2. Liping Su2,
  3. Lihong Liu3,
  4. Yuhuan Gao3,
  5. Quanshun Wang4,
  6. Hang Su5,
  7. Yuhuan Song6,
  8. Huilai Zhang7,
  9. Jing Shen8,
  10. Hongmei Jing9,
  11. Shuye Wang10,
  12. Xinan Cen11,
  13. Hui Liu12,
  14. Aichun Liu13,
  15. Zengjun Li14,
  16. Jianmin Luo15,
  17. Jianxia He16,
  18. Jingwen Wang17,
  19. O. A. O’Connor18 and
  20. Daobin Zhou1⇑
  1. 1Department of Hematology, Peking Union Medical College Hospital, Beijing 100730, China
  2. 2Department of Hematology, Shanxi Provincial Cancer Hospital, Taiyuan 030013, China
  3. 3Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
  4. 4Department of Hematology, Chinese PLA General Hospital, Beijing 100039, China
  5. 5Department of Lymphoma, the 307 Hospital of PLA, Beijing 100071, China
  6. 6Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing 100142, China
  7. 7Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
  8. 8Department of Hematology, Beijing Friendship Hospital, Beijing 100050, China
  9. 9Department of Hematology, Peking University Third Hospital, Beijing 100191, China
  10. 10Department of Hematology, the First Affiliated Hospital of Harbin Medical University, Harbin 150081, China
  11. 11Department of Hematology, Peking University First Hospital, Beijing 100034, China
  12. 12Department of Hematology, Beijing Hospital, Beijing 100730, China
  13. 13Department of Lymphoma, Harbin Medical University Cancer Hospital, Harbin 150081, China
  14. 14Lymphoma Diagnosis and Treatment Center, Institute of Hematology and Blood Diseases Hospital, Tianjin 300052, China
  15. 15Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  16. 16Department of Hematology, Shanxi Provincial People’s Hospital, Taiyuan 030012, China
  17. 17Department of Hematology, Beijing Tongren Hospital, Beijing 100730, China
  18. 18Columbia University Medical Center, New York 10032-3784, NY, USA
  1. Correspondence to: Daobin Zhou, E-mail: zhoudb{at}pumch.cn
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords